Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Jeet will be a trusted partner in cardiovascular care
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
The move signals a major expansion in access to next-generation weight-loss therapies
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
